共 40 条
Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling
被引:112
作者:
Hwang, So-Young
[1
,2
]
Deng, Xianming
[3
]
Byun, Sanguine
[1
,2
]
Lee, Chan
[1
,2
]
Lee, Seung-Joo
[4
]
Suh, Hyunsuk
[4
]
Zhang, Jianming
[1
,2
]
Kang, Qiaofeng
[3
]
Zhang, Ting
[3
]
Westover, Kenneth D.
[5
]
Mandinova, Anna
[1
,2
,6
]
Lee, Sam W.
[1
,2
,6
]
机构:
[1] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA
[2] Harvard Med Sch, Charlestown, MA 02129 USA
[3] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China
[4] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[5] Univ Texas SW Med Ctr Dallas, Dept Biochem & Radiat Oncol, Dallas, TX 75390 USA
[6] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA
基金:
美国国家卫生研究院;
中国国家自然科学基金;
关键词:
CANCER-CELLS;
WNT PATHWAY;
FUNCTIONAL INTERACTION;
XENOPUS EMBRYOS;
HIGH-FREQUENCY;
COLON-CANCER;
TCF COMPLEX;
ACTIVATION;
TRANSCRIPTION;
INHIBITION;
D O I:
10.1016/j.celrep.2016.05.071
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
The Wnt/beta-catenin signaling pathway plays a major role in tissue homeostasis, and its dysregulation can lead to various human diseases. Aberrant activation of beta-catenin is oncogenic and is a critical driver in the development and progression of human cancers. Despite the significant potential of targeting the oncogenic beta-catenin pathway for cancer therapy, the development of specific inhibitors remains insufficient. Using a T cell factor (TCF)-dependent luciferase-reporter system, we screened for small-molecule compounds that act against Wnt/beta-catenin signaling and identified MSAB (methyl 3-{[(4-methylphenyl) sulfonyl]amino}benzoate) as a selective inhibitor of Wnt/beta-catenin signaling. MSAB shows potent anti-tumor effects selectively on Wnt-dependent cancer cells in vitro and in mouse cancer models. MSAB binds to beta-catenin, promoting its degradation, and specifically downregulates Wnt/beta-catenin target genes. Our findings might represent an effective therapeutic strategy for cancers addicted to the Wnt/beta-catenin signaling pathway.
引用
收藏
页码:28 / 36
页数:9
相关论文